Private equity bidding round: PolyPeptide names EQT, IDG
PolyPeptide Group AG has shortlisted private equity bidding round EQT AB and IDG Capital for the next bidding round amid takeover interest in the Swiss
CSL stock decline Deepens as Shares Hit Seven-Year Low
The recent CSL stock decline highlights investor concerns over the company's strategic postponement of the vaccine division spin-off amid broader challenges in